Viking Therapeutics (VKTX) Return on Assets [ROA] (2015 - 2026)
Viking Therapeutics' Return on Assets [ROA] came in at -99.11% for Q2 2026, down 73.99 percentage points from -25.12% a year earlier and down 23.27 percentage points from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Viking Therapeutics' Return on Assets [ROA] was -48.44%, down 24.80 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of -32.66 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -23.64% in FY2024 (+13.91 pp), -37.55% in FY2023 (-0.44 pp), -37.11% in FY2022 (-13.27 pp) and -23.84% in FY2021 (-8.06 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q4 2017.
- Year-over-year, Return on Assets [ROA] has declined for six consecutive quarters, with an average year-over-year change of -22.95 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q1 2024 (a gain of 29.62 percentage points), and the weakest in Q2 2026 (a drop of 73.99 percentage points).
- Business Quant data shows VKTX's Return on Assets [ROA] at -75.83% (Q1 2026), -54.06% (Q4 2025) and -35.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.14% |
| 10 | Viking Therapeutics | 2.99 Bn | 464.96 Mn | - | -99.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.11% |
| Mar 31, 2026 | -75.83% |
| Dec 31, 2025 | -54.06% |
| Sep 30, 2025 | -35.07% |
| Jun 30, 2025 | -25.12% |
| Mar 31, 2025 | -19.41% |
| Dec 31, 2024 | -16.35% |
| Sep 30, 2024 | -14.22% |
| Jun 30, 2024 | -13.03% |
| Mar 31, 2024 | -17.12% |
| Dec 31, 2023 | -26.85% |
| Sep 30, 2023 | -23.44% |
| Jun 30, 2023 | -29.28% |
| Mar 31, 2023 | -46.74% |
| Dec 31, 2022 | -41.98% |
| Sep 30, 2022 | -35.95% |
| Jun 30, 2022 | -31.76% |
| Mar 31, 2022 | -28.44% |
| Dec 31, 2021 | -25.59% |
| Sep 30, 2021 | -23.55% |
API Access
Viking Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();